First American Bank’s MIRA Pharmaceuticals MIRA Stock Holding History

First American Bank’s Portfolio MIRA Stock Details MIRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.8K	Hold	60,000	–	–	﹤0.01%	205
2026 Q1	$64.2K	Hold	60,000	–	–	﹤0.01%	188
2025 Q4	$90.6K	Buy	60,000 +10,000	+20%	+$14.7K	0.01%	177
2025 Q3	$68K	Buy	50,000 +30,000	+150%	+$43.5K	﹤0.01%	176
2025 Q2	$24.2K	Hold	20,000	–	–	﹤0.01%	171
2025 Q1	$19.6K	Hold	20,000	–	–	﹤0.01%	165
2024 Q4	$22.8K	Hold	20,000	–	–	﹤0.01%	169
2024 Q3	$26K	Hold	20,000	–	–	﹤0.01%	166
2024 Q2	$12.7K	Hold	20,000	–	–	﹤0.01%	168
2024 Q1	$22K	Buy	+20,000	New	+$21.7K	﹤0.01%	169

Other funds holding MIRA

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

First American Bank's MIRA Position: Q2 2026 in Review

First American Bank held its MIRA Pharmaceuticals (MIRA) position steady in Q2 2026 at 60,000 shares worth $56.8K. The position accounts for ﹤0.01% of the portfolio, ranked #205.

First American Bank first reported a position in MIRA in Q1 2024 and has held it in 10 quarters since. The position peaked at $90.6K in Q4 2025. 2 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

First American Bank held 60,000 shares of MIRA Pharmaceuticals worth $56.8K as of Q2 2026.
First American Bank left its MIRA Pharmaceuticals share count unchanged in Q2 2026.
MIRA Pharmaceuticals made up ﹤0.01% of First American Bank's portfolio in Q2 2026, its #205 holding.
First American Bank first reported a position in MIRA Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
First American Bank's MIRA Pharmaceuticals position peaked at $90.6K in Q4 2025.
2 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.